SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-012236
Filing Date
2006-02-27
Accepted
2006-02-27 16:24:26
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-5750_110k.htm 10-K 2123463
2 SUBSIDIARIES OF THE REGISTRANT a06-5750_1ex21.htm EX-21 3118
3 CONSENTS OF EXPERTS AND COUNSEL a06-5750_1ex23d1.htm EX-23.1 4248
4 302 CERTIFICATION a06-5750_1ex31d1.htm EX-31.1 9592
5 302 CERTIFICATION a06-5750_1ex31d2.htm EX-31.2 10522
6 906 CERTIFICATION a06-5750_1ex32d1.htm EX-32.1 5878
7 906 CERTIFICATION a06-5750_1ex32d2.htm EX-32.2 6321
  Complete submission text file 0001104659-06-012236.txt   2164525
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26301 | Film No.: 06646906
SIC: 2834 Pharmaceutical Preparations